Discover a powerful, new (and somewhat unpopular) way to deal with anxiety and depression - without meditation, yoga, gratitude lists, pharmaceuticals and $49 Moleskine journals.
Stephen Murphy, Co-Founder of Prohibition Partners, chats about the upcoming PSYCH Investor Summit taking place on April 21, 2021.
Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality, as psilocybin has shown.
Researchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
There’s new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama doctor Richard C. Shelton.
Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch.
A Phase IIa clinical trial of 5-MeO-DMT for the treatment of alcohol use disorder (AUD) has begun this month.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
